Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 4.05 CAD -0.74% Market Closed
Market Cap: 1.6B CAD

Relative Value

The Relative Value of one CRON stock under the Base Case scenario is hidden CAD. Compared to the current market price of 4.05 CAD, Cronos Group Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CRON Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
22
Median 3Y
8.4
Median 5Y
9.4
Industry
2.6
Forward
8
vs History
4
vs Industry
28
Median 3Y
-5.2
Median 5Y
-5.5
Industry
21.7
Forward
-191.9
vs History
9
vs Industry
11
Median 3Y
29.6
Median 5Y
-8.4
Industry
16.7
vs History
vs Industry
3
Median 3Y
-10.2
Median 5Y
-10.2
Industry
23.1
vs History
26
vs Industry
69
Median 3Y
0.7
Median 5Y
0.9
Industry
2.2
vs History
33
vs Industry
81
Median 3Y
-0.6
Median 5Y
1.1
Industry
2.9
Forward
2.1
vs History
15
vs Industry
41
Median 3Y
-3
Median 5Y
-4.4
Industry
5.5
vs History
vs Industry
50
Median 3Y
0.8
Median 5Y
-1
Industry
13.2
Forward
17.8
vs History
vs Industry
49
Median 3Y
0.7
Median 5Y
-0.9
Industry
16.8
Forward
-16.7
vs History
4
vs Industry
18
Median 3Y
0.9
Median 5Y
-1.7
Industry
15.9
vs History
vs Industry
35
Median 3Y
0.7
Median 5Y
-2.7
Industry
19.2
vs History
30
vs Industry
81
Median 3Y
-0.2
Median 5Y
0.4
Industry
1.9

Multiples Across Competitors

CRON Competitors Multiples
Cronos Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Cronos Group Inc
TSX:CRON
1.6B CAD 8.5 31.1 -45.4 -15.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.6B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
208.2B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.4B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
CA
Cronos Group Inc
TSX:CRON
Average P/E: 24.8
31.1
2%
15.6
US
Eli Lilly and Co
NYSE:LLY
55
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Cronos Group Inc
TSX:CRON
Average EV/EBITDA: 438.8
Negative Multiple: -45.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Cronos Group Inc
TSX:CRON
Average EV/EBIT: 1 881.3
Negative Multiple: -15.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3